Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > KWSdeluxe --care to elaborate on your price prediction???

<< Previous

Bullboard Posts

Next >>

Comment by canadafanon Apr 08, 2021 8:17am

308 Views

Post# 32955332

RE:RE:KWSdeluxe --care to elaborate on your price prediction???

FYI for those curious
the ps price is roughly $16/ billion of buy- out...
that is USA$ btw.
roughly $20ps CDN/ billion.
Onc has traded as high as $60 usd , Way back.
a $3 billion buy out would bring that easy.
I do not think we are at the buy out stage yet.
I do think, there will be either or both announced this year,.
1. a stage 3 enrolment/ partnership with $$ attached.( Mac)
2 a longer development contract/ partnership to bring the Car-t to market.
either of those 2 price doubles.
both, double again.

<< Previous

Bullboard Posts

Next >>

Corus reports Q1 profit drop in the face of falling revenue